Comparison of real‐world adherence, health care resource utilization and costs for newly initiated valsartan/amlodipine single‐pill combination vs angiotensin‐receptor blocker/calcium‐channel blocker free combination therapy

Abstract Authors: Baser O, Andrews LM, Wang L, Xie L. Objective: To compare adherence, healthcare costs and utilization of valsartan/amlodipine single-pill combination (SPC) and angiotensin-receptor blocker/calcium-channel blocker multiple-pill free-combination...